期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Galactose-modified enzymatic synthesis of poly(amino-co-ester)micelles for co-delivery miR122 and sorafenib to inhibit hepatocellular carcinoma development 被引量:2
1
作者 Jianhua Xie Yao Lu +2 位作者 baiqing yu Jun Wu Jie Liu 《Chinese Chemical Letters》 SCIE CAS CSCD 2020年第5期1173-1177,共5页
Nanomaterials as drug carriers hold promise for the treatment of carcinomas,but integrating multiple functions into a single vector is difficult.In this study,we aim to develop efficie nt materials as vectors for co-d... Nanomaterials as drug carriers hold promise for the treatment of carcinomas,but integrating multiple functions into a single vector is difficult.In this study,we aim to develop efficie nt materials as vectors for co-delivery of microRNA-122(miR-122)and sorafenib(SRF).We successfully synthesized amphiphilic galactose-modified PEGylated poly(ami no-co-ester)(Gal-PEG-PPMS)copolymers consisted of hydrophilic Gal-PEG5 k chain segments and hydrophobic poly(ω-pentadecalactone-co-N-methyldiethyleneamine-co-sebacic acid)chain segments,which self-assembled to form cationic micelles at pH 5.2.The results showed that the micelles could encapsulate SRF and bind miR122 simultaneously,increase cellular uptake efficiency.Furthermore,the micelles showed favorable transfection efficiency in enhancing miR122 expression level,the migration and invasion ability of hepatocellular carcinoma(HCC)cells we re significantly inhibited after being tra nsfected with miR122-loaded micelles.Most importantly,the co-delivery micelles decreased cell activities of HepG2 cells,which was more effective than miR122 or SRF loaded micelles alone.Collectively,Gal-PEG-PPMS nanoparticles are promising multifunctional carriers for miR122 and SRF co-delivery system to treat HCC. 展开更多
关键词 Micelles miR122 SORAFENIB Hepatocellular carcinoma CO-DELIVERY
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部